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As the foreword to this book states, our passage into the new
millennium gives the opportunity to use the medical achievements
of the past 1000 years to develop treatment strategies for the
future. It describes and explains the roles that imaging plays in
the emergence of new diagnostic and therapeutic procedures.
Increased knowledge regarding the genetics and the molecular
biology of tumour development offers the potential of new targets
of therapy. However, devising methods with which to determine
the existence, and the evaluation, of novel diagnostic and therapeutic
strategies in cancer remains a challenge. Improved imaging techni-
ques and the radiolabelling of tracers and drugs are making non-
invasive imaging of molecular targets possible, thereby facilitating
the translation of these scientiﬁc breakthroughs into clinical practice.
This book provides an excellent review of imaging technologies
and their role within oncological treatment strategies. It begins with
a basic science chapter giving a very structured and readable back-
ground to the molecular genetics of cancer, cancer cell
immunology, biochemistry and pathology. This chapter explains
DNA replication and the genetic mutations that give rise to the acti-
vation of oncogenes and the inactivation of tumour suppressor genes
in neoplasia. It discusses the role of cellular immunology, including
T-cell and B-cell immunity and cytokine interactions, providing an
insight into active and passive immunotherapy in the treatment of
cancer. This gives the reader a good platform from which to proceed
with the subject of molecular targeting.
The following chapters cover the principles of each of the imaging
technologies available, and include the techniques of ultrasound,
computerised tomography (CT), magnetic resonance imaging
(MRI) and spectroscopy (MRS), single positron emission tomogra-
phy (SPECT) and positron emission tomography (PET). Each
chapter addresses the difﬁcult topic of technique methodology and
the authors manage to describe this in a surprisingly straightforward
manner. Obviously, some chapters are slightly more complicated
than others, but in general the points are made clearly and simply.
Having set the scene and discussed the various advantages and
disadvantages of each imaging method, the second part of the book
gives examples of the ways in which they can be used to image
molecular targets utilising, for instance, radiolabelled antibodies
and radiopharmaceuticals. Chapter 5 provides an overview of some
of the radiopharmaceuticals that target tumours, concentrating on
the rationale and the results of these studies.
The radiolabelled antibody chapter, Chapter 6, is particularly
interesting. It covers the production of monoclonal antibodies
from hybridomas, made from the fusion of myeloma cells and
B-lymphocytes, through to current phage library techniques. The
importance of optimising antibody selection for tumour targeting,
in particular the kinetics according to fragment size, is highlighted.
Finally, the radioisotopes available for antibody radiolabelling are
discussed. The following chapter expands upon this theme by
demonstrating the possibility of radioimmunodetection of different
tumour-marker expressing cancers using commercially available
monoclonal antibody conjugates, such as ProstaScint (Cytogen)
for prostate carcinoma, CEA-Scan (Immunomedics) for colorectal
cancer and OncoScint (Cytogen) for colorectal and ovarian cancer.
The potential value of polymer-drug conjugates and macro-
molecular contrast media imaged with MRI are described, together
with the use of paramagnetic radionuclides to label monoclonal
antibodies, and newer contrast agents, to aid in speciﬁcally target-
ing these for magnetic resonance imaging. This, thereby, expands
the use from gadolinium-based interstitial agents to agents tailored
to speciﬁc clinical applications.
Dynamic PET images have been likened to displaying ‘slices of
life’, however the expense of performing these scans generally
conﬁnes their use to academic and teaching medical centres. On
the other hand, SPECT is more accessible. Both techniques provide
3-dimensional images of the distribution of radiotracers and the
chapters regarding targeted SPECT and PET provide data and
images of gallium-67, thallium-201,
99mtechnetium-sestamibi scans
in SPECT and ﬂuorine-18 ﬂuorodeoxyglucose scanning in PET.
The main thrust of these chapters is to describe those radiotracers
with established roles in oncology, with suggestions of those requir-
ing further investigation.
The ﬁnal third of the book expands upon the roles of the differ-
ent techniques for imaging the processes important in tumour
development and survival, in particular angiogenesis, hypoxia,
apoptosis and signal transduction. The potential for imaging
anti-cancer drugs themselves, including anti-sense oligonucleotides,
gene delivery and expression, is also discussed. Illustrations are
shown and the images and results are discussed providing a vast
array of potential and future applications for targeting imaging.
Overall, this is a very informative, readable book. The chapter sizes
are easily digestible and there is a clear progression through the book
presenting a succinct and balanced picture of the methodologies
available. The black and white images of the techniques and the
targets help to enlighten the reader visually regarding the text. I thor-
oughly enjoyed reading the book and learning from it. I would
recommend it to both the reader with some knowledge wishing to
explore the topic further as well as to those wanting a basic introduc-
tion and background to the subject.
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